Chronic Myeloid Leukemia

CML VACCINE

True Chronic Myeloid Leukemia Specific Antigen Vaccines
January 26, 2012, Johnny Silva Cancer Research

Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood

Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire

Southampton Scientists Develop New Cancer Vaccine
March 2011, Express Healthcare

Inovio Starts Phase II Study for Leukemia DNA Vaccine
February 2, 2011, Pharmapolis

Patient Trials of New Leukemia Cancer Vaccine Begun
January 31, 2011, Science Daily

Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com

University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive

WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
October 2010, CMLHope.Com

FDA grants Orphan Drug status to novel CML vaccine
August 2010,  The Leukemia and Lymphoma Society of Canada

BioSante Announces FDA Orphan Drug Designation For GVAX Chronic Myeloid Leukemia Cancer Vaccine
June 2010, Medical News Today

WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
April 2010, International Journal of Medical Sciences

BioSante Announces Positive Leukemia Vaccine Results
March 2010, BioSante Pharmaceuticals

Vaccine may cure chronic myeloid leukemia CML
January 10, 2010, Health Newstrack

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients
January 2010, The Medical news

Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
March 2006, clinicaltrials.gov
 
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
December 2005, clinicaltrials.gov

CML Vaccine Gives Uneven Results in Control of Residual Disease
December 12, 2005, Cancerpage.com